Quotes 5-day view Delayed Nasdaq
2 531 884
1 845 164
1 498 200
1 201 985
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. The Company is engaged in the development of cancer immunotherapies. To unlock the potential of cancer immunotherapy, the Company is targeting a set of immune processes by which cancer cells evade immune recognition and attack. Its programs are built upon insights about how to improve the immune systemâ€™s recognition and elimination of cancer cells.
Ratings of Surface Oncology, Inc.
All news about SURFACE ONCOLOGY, INC.
06/10 SURFACE ONCOLOGY, INC. : Submission of Matters to a Vote of Security Holders (f..
06/04 SECTOR UPDATE : Health Care Stocks Trade Higher Pre-Bell Friday
06/04 Surface Oncology in Clinical Trial Collaboration With Roche
06/04 SURFACE ONCOLOGY : to Collaborate With Roche for Testing Liver Cancer Combinati..
06/04 SURFACE ONCOLOGY : SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monoth..
06/04 SURFACE ONCOLOGY, INC. : Other Events, Financial Statements and Exhibits (form ..
06/04 SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monotherapy Activity in..
06/04 SURFACE ONCOLOGY : to Collaborate with Roche on Immuno-Oncology Study Evaluatin..
06/04 Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluatin..
05/18 SURFACE ONCOLOGY : BTIG Initiates Surface Oncology at Buy Rating With $17 Price..
05/05 SURFACE ONCOLOGY : Earnings Flash (SURF) SURFACE ONCOLOGY Posts Q1 Revenue $1.6..
05/05 SURFACE ONCOLOGY : Management's Discussion and Analysis of Financial Condition ..
05/05 SURFACE ONCOLOGY : Reports Financial Results and Corporate Highlights for First..
05/05 SURFACE ONCOLOGY, INC. : Results of Operations and Financial Condition, Financi..
05/03 SURFACE ONCOLOGY, INC. : Entry into a Material Definitive Agreement (form 8-K)
News in other languages on SURFACE ONCOLOGY, INC.
Analyst Recommendations on SURFACE ONCOLOGY, INC.
Chart SURFACE ONCOLOGY, INC.
Technical analysis trends SURFACE ONCOLOGY, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Neutral
Number of Analysts
Average target price
Last Close Price
Spread / Highest target
Spread / Average Target
Spread / Lowest Target